Elite Pharmaceuticals competitorsClear all

Elite Pharmaceuticals's top competitors include Obsidian Therapeutics, Z Factor, Amarillo Biosciences and SIGA Technologies.
Elite Pharmaceuticals
Elite Pharmaceuticals
Elite Pharmaceuticals develops oral controlled-release products for the pain management, allergy, cardiovascular, and infection areas.
Obsidian Therapeutics
Obsidian Therapeutics
Obsidian Therapeutics aspires to extend adoptive immunotherapy to every patient with cancer.
Z Factor
Z Factor
Z Factor Limited is a drug discovery company.
Amarillo Biosciences
Amarillo Biosciences
Amarillo Biosciences is a specialty biopharmaceutical company working in Phase 2 human clinical trials with a well-characterized therapeutic agent, interferon-alpha, in a proprietary low-dose oral formulation.
SIGA Technologies
SIGA Technologies
At SIGA, we specialize in developing therapeutic solutions for some of the most lethal pathogens smallpox.
Founding Date
Founding Date
N/A
Founding Date
2015
Founding Date
2014
Founding Date
N/A
Founding Date
N/A
Type
Type
Public
Type
Private
Type
Private
Type
Public
Type
Public
Tags
Locations
Locations
Northvale, US HQ
Locations
Cambridge, US HQ
Locations
Babraham, GB HQ
Locations
Amarillo, US HQ
Locations
New York, US HQ
Corvallis, US
New York, US
Employees
Employees
3519% decrease
Employees
552% decrease
Employees
4
Employees
250% decrease
Employees
41
Valuation ($)
Valuation ($)
64.6 m
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
9 m
Valuation ($)
535.9 m
Alexa Website Rank
Alexa Website Rank
N/A
Alexa Website Rank
N/A
Alexa Website Rank
379840
Alexa Website Rank
315433
Alexa Website Rank
566947
Employee Rating
Employee Rating
2.9
Employee Rating
N/A
Employee Rating
N/A
Employee Rating
N/A
Employee Rating
2.2

Financial

Revenue (est.)
Revenue (est.)
$18m (FY, 2020)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$11.7k (FY, 2019)
Revenue (est.)
$26.7m (FY, 2019)
Cost of goods
Cost of goods
$10m (FY, 2020)
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$8.8k (FY, 2019)
Cost of goods
$1.8m (FY, 2019)
Gross profit
Gross profit
$8m (FY, 2020)
Gross profit
N/A
Gross profit
N/A
Gross profit
$3k (FY, 2019)
Gross profit
$25m (FY, 2019)
Net income
Net income
($2.2m) (FY, 2020)
Net income
N/A
Net income
N/A
Net income
($1.6m) (FY, 2019)
Net income
($7.2m) (FY, 2019)

Funding

Latest funding round
Latest funding round
N/A
Latest funding round
$ 49.5m (almost 3 years ago)
Latest funding round
$ 9.1m (over 3 years ago)
Latest funding round
N/A
Latest funding round
N/A
Total funding raised
Total funding raised
N/A
Total funding raised
$ 49.5m
Total funding raised
$ 9.1m
Total funding raised
N/A
Total funding raised
N/A
For sources of this data, please see the company profile

View company profiles

Obsidian Therapeutics
HQ
Cambridge, US
Employees
55↓ 2% decrease

Obsidian Therapeutics aspires to extend adoptive immunotherapy to every patient with cancer.

View company
Z Factor
HQ
Babraham, GB
Employees
4

Z Factor Limited is a drug discovery company.

View company
Amarillo Biosciences
HQ
Amarillo, US
Employees
2↓ 50% decrease

Amarillo Biosciences is a specialty biopharmaceutical company working in Phase 2 human clinical trials with a well-characterized therapeutic agent, interferon-alpha, in a proprietary low-dose oral formulation.

View company
SIGA Technologies
HQ
New York, US
Employees
41

At SIGA, we specialize in developing therapeutic solutions for some of the most lethal pathogens smallpox.

View company